A carregar...
Erlotinib in the treatment of advanced pancreatic cancer
Single agent gemcitabine has been the mainstay of therapy for advanced pancreatic cancer over the past decade. Multiple trials of newer chemotherapeutic agents both alone and in combination have yielded disappointing results, spurring the ongoing search for new agents and combinations in this aggres...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2008
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2727779/ https://ncbi.nlm.nih.gov/pubmed/19707431 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|